MX367940B - Inhibidores selectivos de bace1. - Google Patents
Inhibidores selectivos de bace1.Info
- Publication number
- MX367940B MX367940B MX2017010861A MX2017010861A MX367940B MX 367940 B MX367940 B MX 367940B MX 2017010861 A MX2017010861 A MX 2017010861A MX 2017010861 A MX2017010861 A MX 2017010861A MX 367940 B MX367940 B MX 367940B
- Authority
- MX
- Mexico
- Prior art keywords
- bace1 inhibitors
- selective bace1
- selective
- inhibitors
- compound
- Prior art date
Links
- 229940125759 BACE1 protease inhibitor Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente invención proporciona un compuesto de Fórmula II: (ver Fórmula) o una sal aceptable para uso farmacéutico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562119391P | 2015-02-23 | 2015-02-23 | |
PCT/US2016/018160 WO2016137788A1 (en) | 2015-02-23 | 2016-02-17 | Selective bace1 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2017010861A MX2017010861A (es) | 2017-12-11 |
MX367940B true MX367940B (es) | 2019-09-12 |
Family
ID=55442893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017010861A MX367940B (es) | 2015-02-23 | 2016-02-17 | Inhibidores selectivos de bace1. |
Country Status (27)
Country | Link |
---|---|
US (1) | US9522923B2 (es) |
EP (1) | EP3262051B1 (es) |
JP (1) | JP6111001B1 (es) |
KR (1) | KR101945139B1 (es) |
CN (1) | CN107257801B (es) |
AR (1) | AR103680A1 (es) |
AU (1) | AU2016223072B2 (es) |
BR (1) | BR112017013936A2 (es) |
CA (1) | CA2972098A1 (es) |
CL (1) | CL2017002090A1 (es) |
CO (1) | CO2017008382A2 (es) |
CR (1) | CR20170315A (es) |
DO (1) | DOP2017000178A (es) |
EA (1) | EA031546B1 (es) |
EC (1) | ECSP17054980A (es) |
GT (1) | GT201700185A (es) |
IL (1) | IL252969A0 (es) |
MX (1) | MX367940B (es) |
NZ (1) | NZ732940A (es) |
PE (1) | PE20171337A1 (es) |
PH (1) | PH12017501523A1 (es) |
SG (1) | SG11201705764SA (es) |
SI (1) | SI3262051T1 (es) |
TN (1) | TN2017000355A1 (es) |
TW (1) | TWI627177B (es) |
WO (1) | WO2016137788A1 (es) |
ZA (1) | ZA201704293B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
US9938266B2 (en) | 2015-03-19 | 2018-04-10 | Eli Lilly And Company | Selective BACE1 inhibitors |
AR104241A1 (es) | 2015-04-29 | 2017-07-05 | Lilly Co Eli | Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos |
JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JO3633B1 (ar) | 2015-09-16 | 2020-08-27 | Katholieke Univ Leuven Ku Leuven Research & Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
SG11201808270PA (en) | 2016-03-31 | 2018-10-30 | Janssen Pharmaceuticals Inc | Substituted indoline derivatives as dengue viral replication inhibitors |
EP3436435B1 (en) | 2016-03-31 | 2021-05-12 | Janssen Pharmaceuticals, Inc. | Substituted indole derivatives as dengue viral replication inhibitors |
JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
MA44502A (fr) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals Inc | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
CN109641052A (zh) * | 2016-08-18 | 2019-04-16 | 伊莱利利公司 | BACE-1抑制剂和抗-N3pGlu Aβ抗体的组合疗法 |
JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
KR102625988B1 (ko) | 2017-05-22 | 2024-01-16 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
KR102625991B1 (ko) | 2017-05-22 | 2024-01-16 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201004961A (en) | 2005-06-14 | 2010-02-01 | Schering Corp | Aspartyl protease inhibitors |
CA2711655C (en) * | 2008-01-18 | 2013-03-05 | Eisai R&D Management Co., Ltd. | Condensed aminodihydrothiazine derivative |
US8637504B2 (en) | 2008-06-13 | 2014-01-28 | Shionogi & Co., Ltd. | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
CN102171221B (zh) | 2008-09-30 | 2013-11-06 | 卫材R&D管理有限公司 | 新的稠合的氨基二氢噻嗪衍生物 |
AR077277A1 (es) | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
JP5554346B2 (ja) | 2009-12-09 | 2014-07-23 | 塩野義製薬株式会社 | 含硫黄複素環誘導体を含有するアルツハイマー症の治療用または予防用医薬組成物 |
US20120245155A1 (en) | 2009-12-11 | 2012-09-27 | Shionogi & Co., Ltd. | Fused heterocyclic compound having amino group |
GB201100181D0 (en) | 2011-01-06 | 2011-02-23 | Eisai Ltd | Fused aminodihydrothiazine derivatives |
GB201101139D0 (en) | 2011-01-21 | 2011-03-09 | Eisai Ltd | Fused aminodihydrothiazine derivatives |
GB201101140D0 (en) * | 2011-01-21 | 2011-03-09 | Eisai Ltd | Fused aminodihydrothiazine derivatives |
US8598161B2 (en) | 2011-05-24 | 2013-12-03 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
WO2014015125A1 (en) | 2012-07-19 | 2014-01-23 | Eisai R&D Management Co., Ltd. | Fused aminodihydrothiazine derivative salts and uses thereof |
GB201212816D0 (en) * | 2012-07-19 | 2012-09-05 | Eisai Ltd | Novel compounds |
TWI593692B (zh) | 2013-03-12 | 2017-08-01 | 美國禮來大藥廠 | 四氫吡咯并噻嗪化合物 |
JO3318B1 (ar) * | 2013-06-18 | 2019-03-13 | Lilly Co Eli | مثبطات bace |
AR104241A1 (es) * | 2015-04-29 | 2017-07-05 | Lilly Co Eli | Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos |
-
2016
- 2016-02-12 AR ARP160100396A patent/AR103680A1/es unknown
- 2016-02-15 TW TW105104352A patent/TWI627177B/zh not_active IP Right Cessation
- 2016-02-17 CR CR20170315A patent/CR20170315A/es unknown
- 2016-02-17 PE PE2017001256A patent/PE20171337A1/es unknown
- 2016-02-17 SG SG11201705764SA patent/SG11201705764SA/en unknown
- 2016-02-17 KR KR1020177023007A patent/KR101945139B1/ko active IP Right Grant
- 2016-02-17 EA EA201791684A patent/EA031546B1/ru not_active IP Right Cessation
- 2016-02-17 EP EP16706731.3A patent/EP3262051B1/en active Active
- 2016-02-17 MX MX2017010861A patent/MX367940B/es active IP Right Grant
- 2016-02-17 JP JP2016558188A patent/JP6111001B1/ja not_active Expired - Fee Related
- 2016-02-17 SI SI201630428T patent/SI3262051T1/sl unknown
- 2016-02-17 CA CA2972098A patent/CA2972098A1/en not_active Abandoned
- 2016-02-17 CN CN201680011583.5A patent/CN107257801B/zh not_active Expired - Fee Related
- 2016-02-17 AU AU2016223072A patent/AU2016223072B2/en not_active Ceased
- 2016-02-17 TN TNP/2017/000355A patent/TN2017000355A1/en unknown
- 2016-02-17 US US15/045,305 patent/US9522923B2/en not_active Expired - Fee Related
- 2016-02-17 BR BR112017013936A patent/BR112017013936A2/pt not_active Application Discontinuation
- 2016-02-17 WO PCT/US2016/018160 patent/WO2016137788A1/en active Application Filing
- 2016-02-17 NZ NZ732940A patent/NZ732940A/en not_active IP Right Cessation
-
2017
- 2017-06-18 IL IL252969A patent/IL252969A0/en unknown
- 2017-06-23 ZA ZA2017/04293A patent/ZA201704293B/en unknown
- 2017-07-31 DO DO2017000178A patent/DOP2017000178A/es unknown
- 2017-08-01 GT GT201700185A patent/GT201700185A/es unknown
- 2017-08-16 CO CONC2017/0008382A patent/CO2017008382A2/es unknown
- 2017-08-16 CL CL2017002090A patent/CL2017002090A1/es unknown
- 2017-08-22 EC ECIEPI201754980A patent/ECSP17054980A/es unknown
- 2017-08-23 PH PH12017501523A patent/PH12017501523A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501523A1 (en) | Selective bace1 inhibitors | |
MX2017006266A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos. | |
PH12018501151A1 (en) | Tank-binding kinase inhibitor compounds | |
PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
MA39749A (fr) | Dérivés de pipéridine-dione | |
TW201613872A (en) | IRAK4 inhibiting agents | |
MX2016015862A (es) | Compuestos inhibidores de la cinasa de union a tank. | |
EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
MX2015017156A (es) | Inhibidores de bace. | |
PH12018500282A1 (en) | Cgrp receptor antagonists | |
MX2015015841A (es) | Compuestos de fenoxietil dihidro-1h-isoquinolina. | |
MX2016013265A (es) | Análogos de compuestos de 4h-pirazolo[1,5-a]bencimidazol como inhibidores parp. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
MY193239A (en) | Novel b-lactamase inhibitors | |
EA201791099A1 (ru) | Хинолин карбоксамиды для применения в лечении лейкоза | |
PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
MX2018003903A (es) | Compuesto biciclico y uso del mismo para inhibicion de suv39h2. | |
AU2016330503A8 (en) | Therapeutic compounds and methods of use thereof | |
EA201690593A1 (ru) | Новые соединения мочевины | |
EA201791596A1 (ru) | Пиразоловые соединения | |
MX2018002193A (es) | Metodo de uso de quinoxalinilo-piperazinamida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |